Cure My Disease

Don't miss your cure!

 Log in / Sign up

One-Time infusion could train your body to fight cancer from within

NCT ID NCT06539338

Recruiting now Disease control Sponsor: Kite, A Gilead Company Source: ClinicalTrials.gov ↗

First seen Jan 05, 2026 · Last updated Apr 23, 2026 · Updated 12 times

Summary

This early-stage study tests a new gene therapy called INT2104 in 34 adults whose B-cell cancers have returned or not responded to other treatments. The therapy is given as a single intravenous infusion and aims to create cancer-fighting T and natural killer cells inside the body. The main goal is to check safety, but researchers will also look for signs that the treatment is working.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospital MD Anderson

    RECRUITING

    Madrid, 28033, Spain

  • Peter MacCallum Cancer Centre

    RECRUITING

    Melbourne, Victoria, 3000, Australia

  • Westmead Hospital

    RECRUITING

    Westmead, New South Wales, 2145, Australia

Conditions

Explore the condition pages connected to this study.

LYMPHOMAS NON-HODGKIN'S B-CELL PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA